HOME >> BIOLOGY >> NEWS
Schepens Eye Research Institute receives 'Roadmap' grant to develop center for curing eye diseases

Boston, Mass The Schepens Eye Research Institute has been awarded a grant from the National Institutes of Health to form teams of basic and clinical researchers from many disciplines to find cures for blinding eye diseases such as macular degeneration, diabetic retinopathy and glaucoma. The Institute competed with hundreds of organizations for the award. It is the only eye research institute to receive this type of award. The grant is part of a larger initiative known as the "NIH Roadmap," which seeks to find new ways to solve problems that have not yielded to traditional research. NIH is announcing the recipients of these special awards today in Bethesda.

"This is an exciting opportunity to bring enormous energy and new brain power to solve some of the most complex puzzles in eye research," says Darlene Dartt, PhD, the Director of Scientific Affairs at Schepens who is heading up the project. The Institute plans to combine forces with Massachusetts Eye and Ear Infirmary, Harvard Medical School and other Harvard teaching hospitals by enlisting top investigators exploring diseases as diverse as Alzheimer's, rheumatoid arthritis and heart disease to be part of a "think tank" to cure blindness.

As the population ages, the need for new treatments for vision-robbing diseases is becoming critical. Age-related macular degeneration affects more than 1.75 million individuals in the United States. This number is expected to increase to almost 3 million by 2020.Each year 1.3 million Americans over age 20 are diagnosed with diabetic retinopathy. The financial impact and effect on quality of life for people diagnosed with one of these disorders is devastating, says Dartt.

Eye diseases share many of the same underlying mechanisms at work in diseases in other parts of the body, like the heart and the brain. "While experts from these areas often collaborate informally on vision disease, ophthalmology has remained somewhat specialized and in some ways isola
'"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-872-0364
Schepens Eye Research Institute
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Schepens Eye Research Institute scientists at ARVO
2. Obesity gene causes cancer of fat tissue, Schepens scientists find
3. Researchers determine genetic cause of Timothy syndrome
4. Researchers find color sensitive atomic switch in bacteria
5. Researchers identify protein promoting vascular tumor growth
6. Researchers devise potent new tools to curb ivory poaching
7. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
8. Researchers ID chlorophyll-regulating gene
9. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
10. Research suggests new avenue for stopping, preventing colon cancer
11. Researchers develop fast track way to discover how cells are regulated

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... Austin, TX (PRWEB) , ... October 11, 2017 ... ... in August compared the implantation and pregnancy rates in frozen and fresh ... the contribution of progesterone and maternal age to IVF success. , After comparing ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: